Page 139 - Pharmaceutics IV (02-06-01305)
P. 139
Ophthalmic DD: dosage forms
Ocular drug delivery systems
Insoluble ocular inserts:
Mydriasert
271 136
Containers &
packaging
272
Salma E. EL-Habashy
